Martins Bruna Cristina Cardoso, Mesquita Kilvia Helane Cardoso, Costa Iwyson Henrique Fernandes da, Chaves Elana Figueiredo, Firmino Paulo Yuri Milen, Fernandes Paula Frassinetti Castelo Branco Camurça, Fonteles Marta Maria de França
Pharmacy Department, Postgraduate Program in Pharmaceutical Sciences, Federal University of Ceará, Fortaleza, Ceará, Brazil.
College of Economics, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Transplant Proc. 2020 Jun;52(5):1294-1298. doi: 10.1016/j.transproceed.2020.02.070. Epub 2020 Apr 17.
Kidney transplant is considered the best treatment of rehabilitation for chronic kidney disease, but clinical and/or surgical complications may occur after transplant. The study aimed to assess the cost of complications after kidney transplant.
This is a descriptive, retrospective, and exploratory study that used data from Hospital Information System ("Sistema de Informação Hospitalar"). We identified the patients with records of kidney transplant in the states of northern and northeastern Brazil in 2013. These patients were followed up through the records, specifically from 2013 to 2017. The variables analyzed were sex, age, and period after transplant of readmissions (early, intermediate, or late), the main complications within 4 years after the kidney transplant, and cost of hospital admissions.
There were 893 patients with records of kidney transplant in the regions of the study. During the follow-up period, 319 patients had complications. Most hospital readmissions involved male patients (63.6%; n = 203). Mean age was 45 (SD, 15.14) years. Patients developed complications mainly in the early period after transplant (70.22%; n = 224). The number of hospital admissions was 758. The main complications were regarding urinary tract (72.02%; n = 546), infections (19.79%; n = 150), and vascular and/or pulmonary (2.90%; n = 22). The total cost for the treatment of these complications was US $528,329.51.
By analyzing the data it was possible to identify that there is a significant cost involved in the treatment of complications after kidney transplant.
肾移植被认为是慢性肾病康复的最佳治疗方法,但移植后可能会出现临床和/或手术并发症。本研究旨在评估肾移植后并发症的成本。
这是一项描述性、回顾性和探索性研究,使用了医院信息系统(“Sistema de Informação Hospitalar”)的数据。我们确定了2013年巴西北部和东北部各州有肾移植记录的患者。通过这些记录对这些患者进行随访,具体时间为2013年至2017年。分析的变量包括性别、年龄、再次入院的移植后时期(早期、中期或晚期)、肾移植后4年内的主要并发症以及住院费用。
研究区域内有893例有肾移植记录的患者。在随访期间,319例患者出现并发症。大多数再次入院的患者为男性(63.6%;n = 203)。平均年龄为45岁(标准差,15.14)。患者主要在移植后的早期出现并发症(70.22%;n = 224)。住院次数为758次。主要并发症涉及泌尿系统(72.02%;n = 546)、感染(19.79%;n = 150)以及血管和/或肺部(2.90%;n = 22)。治疗这些并发症的总费用为528,329.51美元。
通过分析数据可以确定,肾移植后并发症的治疗涉及大量成本。